The combined use of antiviral agents from three or more classes of drugs to treat patients with human immunodeficiency virus (HIV) infection. HAART reduces the number of viruses circulating in the blood (viral load), and prolongs life and disease-free survival. Reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors are used in HAART.
HIV/AIDS treatment involves the administration of a personalized amalgamation or pharmacological concoction comprising three or more antiretroviral medications.